학술논문

REDUCTION OF TYPE 1 AND TYPE 2 MYOCARDIAL INFARCTIONS IN PATIENTS TREATED WITH ALIROCUMAB: INSIGHTS FROM THE ODYSSEY TRIAL
Document Type
Abstract
Source
In Journal of the American College of Cardiology 12 March 2019 73(9) Supplement 1:4-4
Subject
Language
ISSN
0735-1097